As supplies of home COVID-19 testing are either limited or completely depleted at CVS and Walgreens sites across the United States, Dr Anthony Fauci, chief medical adviser to President Joe Biden, said the supply of tests COVID-19 at home available to Americans “will improve dramatically” in January.
Fauci told ABC’s “This Week” Sunday (December 26) that coronavirus testing is “very important” as the omicron variant increases in the United States and around the world, according to an article in the Washington Post Monday (December 27).
“I think things will improve considerably as January approaches, but that doesn’t help us today and tomorrow,” he said in the ABC interview.
Last week, the Biden administration announced a plan to offer 500 million home tests to Americans in January, noting on Tuesday (December 21) as home testing stocks ran out, “I don’t think anyone who predicted this was going to spread as quickly as before.
Centers for Disease Control and Prevention director Rochelle Walensky said on Tuesday officials had “worked hard as we planned because we knew that omicron had this capacity to scale up at this rate.”
For those who are able to find the home tests, they might face limitations, including a limit of four tests at Walgreens.
Related: Goldman: COVID surge could reduce demand for elective medical procedures in 2022
Meanwhile, recovery of volumes from hospital and MedTech procedures could be delayed, according to a report from Goldman Sachs, which indicates that there could be at least one more coronavirus outbreak once the omicron variant wears off.
A future resurgence of the coronavirus could slow the number of elective procedures hospitals are able to perform and increase the shortage of nurses in the healthcare sector until spring, according to the report.
By mid-2022, “vaccines, natural immunity, antivirals, and a better overall management experience with COVID are expected to increase the chances of a cure” for the healthcare industry, according to the Goldman Sachs report.